Mi‐Ae Jang

1.7k total citations
105 papers, 894 citations indexed

About

Mi‐Ae Jang is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Mi‐Ae Jang has authored 105 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 22 papers in Genetics and 16 papers in Hematology. Recurrent topics in Mi‐Ae Jang's work include Connective tissue disorders research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (6 papers). Mi‐Ae Jang is often cited by papers focused on Connective tissue disorders research (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (6 papers). Mi‐Ae Jang collaborates with scholars based in South Korea, United States and Norway. Mi‐Ae Jang's co-authors include Chang‐Seok Ki, Per Bruheim, Jie Xu, Jun Hee Kim, Eun Jung Kim, Elizabeth Gould, Chul Won Choi, Jong‐Won Kim, Sewan Choi and Hee Bong Shin and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mi‐Ae Jang

94 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mi‐Ae Jang South Korea 17 257 124 120 104 92 105 894
Shinobu Tamura Japan 18 215 0.8× 69 0.6× 174 1.4× 114 1.1× 134 1.5× 88 907
Sandra Beer‐Hammer Germany 24 699 2.7× 128 1.0× 153 1.3× 98 0.9× 110 1.2× 56 1.5k
Zhenhua Xu China 20 310 1.2× 56 0.5× 250 2.1× 63 0.6× 72 0.8× 56 1.8k
Giulio Kleiner United States 16 570 2.2× 70 0.6× 97 0.8× 62 0.6× 83 0.9× 32 977
José Peña Spain 23 375 1.5× 93 0.8× 149 1.2× 167 1.6× 153 1.7× 100 1.8k
Chanin Limwongse Thailand 20 511 2.0× 243 2.0× 75 0.6× 45 0.4× 96 1.0× 94 1.2k
Hidenori Matsuo Japan 25 364 1.4× 49 0.4× 106 0.9× 115 1.1× 165 1.8× 110 1.8k
Ju Gao China 14 335 1.3× 122 1.0× 66 0.6× 62 0.6× 47 0.5× 67 797
Raffaella Cascella Italy 18 417 1.6× 92 0.7× 62 0.5× 78 0.8× 94 1.0× 67 1000
Huiyi Chen United States 17 348 1.4× 37 0.3× 90 0.8× 83 0.8× 128 1.4× 53 1.0k

Countries citing papers authored by Mi‐Ae Jang

Since Specialization
Citations

This map shows the geographic impact of Mi‐Ae Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mi‐Ae Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mi‐Ae Jang more than expected).

Fields of papers citing papers by Mi‐Ae Jang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mi‐Ae Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mi‐Ae Jang. The network helps show where Mi‐Ae Jang may publish in the future.

Co-authorship network of co-authors of Mi‐Ae Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Mi‐Ae Jang. A scholar is included among the top collaborators of Mi‐Ae Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mi‐Ae Jang. Mi‐Ae Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Young‐Gon, Shin Yi Jang, June Huh, et al.. (2025). Reassessment of FBN1 variants of uncertain significance using updated ClinGen guidance for PP1/BS4 and PP4 criteria. European Journal of Human Genetics. 33(5). 666–674.
3.
Wang, Sung Eun, Jaechul Lim, Mi‐Ae Jang, et al.. (2025). Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome. Nature Communications. 16(1). 6125–6125. 1 indexed citations
4.
Jang, Mi‐Ae, et al.. (2024). Diffusion-based Wasserstein generative adversarial network for blood cell image augmentation. Engineering Applications of Artificial Intelligence. 133. 108221–108221. 10 indexed citations
5.
Won, Dongju, et al.. (2024). Major Updates in the NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 3.2024. Laboratory Medicine Online. 15(1). 11–20. 4 indexed citations
6.
Jang, Mi‐Ae, Sungsoon Hwang, Young‐Gon Kim, et al.. (2024). Identification of diagnostic challenges in RP1 Alu insertion and strategies for overcoming them. Scientific Reports. 14(1). 25119–25119. 1 indexed citations
7.
Jang, Mi‐Ae, Shin Yi Jang, Duk‐Kyung Kim, et al.. (2024). Overcoming challenges associated with identifying FBN1 deep intronic variants through whole‐genome sequencing. Journal of Clinical Laboratory Analysis. 38(1-2). e25009–e25009. 3 indexed citations
9.
Bruheim, Per, et al.. (2023). Serum-free alginate-C2C12 cells microcapsule as a model of alternative animal protein source. Frontiers in Nutrition. 10. 1184178–1184178. 3 indexed citations
10.
11.
Jang, Mi‐Ae, et al.. (2023). WBC YOLO-ViT: 2 Way - 2 stage white blood cell detection and classification with a combination of YOLOv5 and vision transformer. Computers in Biology and Medicine. 169. 107875–107875. 30 indexed citations
12.
Jo, Sungsin, et al.. (2022). Dikkopf-1 promotes matrix mineralization of osteoblasts by regulating Ca+-CAMK2A- CREB1 pathway. BMB Reports. 55(12). 627–632. 1 indexed citations
13.
14.
Jang, Mi‐Ae, et al.. (2021). Clinical Manifestations and Genetic Analysis of 5 Korean Choroideremia Patients Initially Diagnosed With Retinitis Pigmentosa. Journal of Korean Medical Science. 37(3). e5–e5. 5 indexed citations
15.
Jang, Mi‐Ae, et al.. (2020). A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations. Journal of Korean Medical Science. 35(23). e168–e168. 4 indexed citations
16.
Jang, Mi‐Ae & Chul Won Choi. (2019). Recent insights regarding the molecular basis of myeloproliferative neoplasms. The Korean Journal of Internal Medicine. 35(1). 1–11. 25 indexed citations
17.
Jang, Mi‐Ae, et al.. (2014). Evaluation of the Automated Blood Bank Systems Galileo NEO and QWALYS-3 for ABO-RhD Typing and Antibody Screening. The Korean Journal of Blood Transfusion. 25(3). 235–242. 3 indexed citations
18.
Jang, Mi‐Ae, et al.. (2014). Annual Report on the External Quality Assessment of Diagnostic Genetics in Korea (2013). 36(2). 71–83. 2 indexed citations
19.
Shin, Ho‐Jin, Kihyun Kım, Je‐Jung Lee, et al.. (2014). The t(11;14)(q13;q32) Translocation as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma. Clinical Lymphoma Myeloma & Leukemia. 15(4). 227–235. 18 indexed citations
20.
Jang, Mi‐Ae, Eun‐Hyung Yoo, Kihyun Kım, et al.. (2013). Chronic lymphocytic leukemia in Korean patients: frequent atypical immunophenotype and relatively aggressive clinical behavior. International Journal of Hematology. 97(3). 403–408. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026